Kitov Pharmaceuticals Holdings Ltd. announced that on June 26, 2016 the Board of Directors of the company determined to fill a vacancy on the Board, and to appoint, effective immediately, Mr. Ido Agmon to serve as a director of the company. Mr. Agmon, since 2014, has been a manager of Aviv New-Tech (formerly Aviv Bio-Invest), of which he is a co-founder, and where he is responsible for analysis and evaluation of investments in Israeli and global biomed companies.